valsartan has been researched along with Cerebral Infarction, Middle Cerebral Artery in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, HY; Chisaka, T; Higaki, A; Horiuchi, M; Iwanami, J; Kan-No, H; Kukida, M; Mogi, M; Nakaoka, H; Shan, BS; Tsukuda, K; Wang, XL; Yamauchi, T | 1 |
| Furuno, M; Higaki, J; Horiuchi, M; Inaba, S; Iwai, M; Kanno, H; Mogi, M; Okayama, H; Senba, I; Tomono, Y | 1 |
| Chen, R; Hata, R; Horiuchi, M; Ide, A; Iwai, M; Liu, HW; Okamoto, S; Sakanaka, M; Shiuchi, T | 1 |
| Fujita, T; Horiuchi, M; Iwai, M; Iwanami, J; Li, JM; Min, LJ; Mogi, M; Sakata, A; Tsukuda, K | 1 |
| Hattori, N; Liu, M; Miyamoto, N; Tanaka, R; Urabe, T; Zhang, N | 1 |
5 other study(ies) available for valsartan and Cerebral Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Pre-treatment with LCZ696, an orally active angiotensin receptor neprilysin inhibitor, prevents ischemic brain damage.
Topics: Administration, Oral; Aminobutyrates; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Atrial Natriuretic Factor; Biphenyl Compounds; Brain; Cerebrovascular Circulation; Drug Combinations; Infarction, Middle Cerebral Artery; Male; Mice; Mice, Inbred C57BL; Neprilysin; Oxidative Stress; Protease Inhibitors; Renin; Sodium; Tetrazoles; Valsartan; Water | 2015 |
Exaggeration of focal cerebral ischemia in transgenic mice carrying human Renin and human angiotensinogen genes.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensinogen; Animals; Brain Chemistry; Brain Ischemia; Capillaries; Cerebrovascular Circulation; Humans; Infarction, Middle Cerebral Artery; Male; Mice; Mice, Transgenic; Oxidative Stress; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin; Reverse Transcriptase Polymerase Chain Reaction; Superoxides; Tetrazoles; Valine; Valsartan | 2009 |
Possible inhibition of focal cerebral ischemia by angiotensin II type 2 receptor stimulation.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Brain Chemistry; Brain Ischemia; Cerebrovascular Circulation; Infarction, Middle Cerebral Artery; Laser-Doppler Flowmetry; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NADPH Oxidases; Oxidative Stress; Receptor, Angiotensin, Type 2; Superoxides; Tetrazoles; Valine; Valsartan | 2004 |
Temporary pretreatment with the angiotensin II type 1 receptor blocker, valsartan, prevents ischemic brain damage through an increase in capillary density.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Brain; Brain Injuries; Brain Ischemia; Capillaries; Chemokine CCL2; DNA Damage; Infarction, Middle Cerebral Artery; Mice; Mice, Inbred C57BL; Oxidative Stress; Receptor, Angiotensin, Type 1; Superoxides; Tetrazoles; Valine; Valsartan | 2008 |
Neuroprotective role of angiotensin II type 2 receptor after transient focal ischemia in mice brain.
Topics: Angiotensin II Type 2 Receptor Blockers; Animals; Apoptosis; Brain; Gene Expression Regulation; Infarction, Middle Cerebral Artery; Ischemic Attack, Transient; Male; Mice; Mice, Inbred C57BL; Nerve Tissue Proteins; Neuroprotective Agents; Proto-Oncogene Proteins c-bcl-2; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Reperfusion; Signal Transduction; STAT3 Transcription Factor; Tetrazoles; Time Factors; Valine; Valsartan | 2008 |